Pharmaceuticals giant Merck & Co., Inc. (MRK) on Friday caught some lukewarm commentary from analysts at BMO Capital.
The firm initiated coverage on MRK with a “Market Perform” rating and a $43 price target, which suggests a 13% upside to the stock’s Thursday closing price. BMO Capital said the rating was a valuation call based on that price target.
Merck shares, which have risen about 1% year-to-date, were mostly flat in premarket trading Friday.
The Bottom Line
Shares of Merck (MRK) have a 4.42% dividend yield, based on last night’s closing stock price of $38.03. The stock has technical support in the $36 price area. If the shares can firm up, we see overhead resistance around the $39-$40 price levels.
Merck & Co., Inc. (MRK) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here